United States Generic Drugs Market Forecast

1
United States Generic Drugs Market
Category Drugs Pharmaceuticals Market Report
2
United States Generic Drugs Market Analyst
View United States Generic Drugs Market to be
USD 210 Billion by 2024. Get Free Customization
in this Report Press Release Title United
States Generic Drugs Market to be USD 210 Billion
by 2024. For more Info https//www.renub.com/uni
ted-states-generic-drugs-market-nd.php

3
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.
Research Report Title United States Generic
Drugs Market, By Therapeutic Application Central
Nervous System (CNS), Cardiovascular,
Dermatology, Genitourinary (GU)/Harmonal Drugs,
Respiratory, Anti-infective, Oncology Others,
Companies (Teva, Mylan N.V., Sandoz, Endo
Pharmaceuticals, Lupin Limited, Dr Reddys, Sun
Pharma, Others) Access Full Research  https//
www.renub.com/united-states-off-label-drugs-market
-and-forecast-51-p.php As per Renub Research
analysis United States Generic Drugs Market is
anticipated to be more than USD 210 Billion by
the year 2024. It has approximately 80 share of
total dispensing prescriptions. Now most of the
physicians and hospitals like prescribe generic
drugs as compared to branded drugs.

4
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.
What is a Generic Drug? It is a Pharmaceutical
drug that has the same chemical composition as
patented drug. It has the same Active
Pharmaceutical Ingredient (API) as original, but
may have different manufacturing process,
excipients, color, taste and packaging. It is
only allowed when the patent(s) of on original
drug is expired.   Request a free sample copy of
the report  https//www.renub.com/contactus.php
  Generic Drugs Market in United States In 2007,
the Food and Drug Administration (FDA) launched
the Generic Initiative for Value and Efficiency
(GIVE) to increase the number and a variety of
generic products by modernizing streamlining
approval process for generic drugs in US. For
making a generic drug, pharmaceutical companies
are required to file an Abbreviated New Drug
Application with FDA.   

5
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.

6
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.
Why Generic Drugs are more affordable than
Branded Drugs? A branded drug has to go through
many phases before coming into the market
initial phase is drug discovery, target
identification and validation then Primary
Screening, Secondary Screening, Lead
Optimization, Pre-Clinical Animal Studies and
various other tests. As new drug development is a
complex process and involves various R D of
chemicals, but clinical trials and regulatory
processes are also required to be approved for
human use of drugs. How Drugs Development
Process Works? According to some studies only 5
out of 5000 preclinical drugs are tested on the
human for medical use out of those 5 drugs only 1
is approved by FDA. There are various stages
involved in drug development.  Drug Discovery
and Target Validation In this stage drug
development company chooses a molecule, such as a
protein or gene and test it with a drug. After
testing multiple drugs only a few are selected
for next stage.

7
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.
Preclinical Testing It is divided into
subcomponents in vitro and in vivo testing. In
vitro testing examines drug molecules
interactions in test tubes in the lab setting. In
vivo testing involves test is being done on
animal models and other living cell cultures.
These tests may take several years before going
to next stage. Investigational New Drug
Application Filing At this stage an application
is submitted to FDA before beginning human
clinical trials. At this point FDA will
scrutinize the outcomes of preclinical testing,
side effects and other safety measures for an
experimental drug. When IND got approved by FDA
then it can move onto human trials. After IND
approval a patented drugs' 20 year exclusivity
period begins.  Phase 1 Clinical Studies At
this stage testing involves a small group of
healthy people from a dozen to a few in numbers
and safety is taken as a primary concern. Now all
the side effect of drug, how a drug is absorbed
elimination from the body is tested. Phase 2
Clinical Studies After getting positive outcomes
from Phase1, Phase 2 begins in this phase the
number of patients grows from a few dozen to 100
or more patients who are suffering from disease.
Safety is also a big concern at this point and
short term side effects are also monitored
closely. 

8
United States Generic Drugs Market is projected
to exceed USD 210 Billion by 2024.
Client can Purchase this Report in Sections from
below link https//www.renub.com/united-states-of
f-label-drugs-market-and-forecast-51-p.php Phase
3 Clinical Studies At this stage the number of
patients for drug testing grow from a few hundred
to thousands. It is the longest and costliest of
all components of development process.  New
Drug Application Filing At this point
application is filed to FDA, with all the
research and safety data of initial stages having
tens of thousands to 100,000 or more pages. After
getting affirmation from FDA, Prescription Drug
User Fee Act (PDUFA) date is set 10
months. PDUFA Date and Decision FDA will wait
for PDUFA date for its decision. FDA has 3
choices it can approve a drug, it can deny a
drug or it can request additional information by
sending a Complete Response Later (CRL). If a
drug is approved by FDA, now it becomes
immediately available for commercial
production.   Phase 4 Clinical Studies After 8
steps an approved drug can used for medical
purpose, but it doesn't mean it is not under
scrutiny of FDA, FDA can request long-term safety
measures, side effect and adverse effect of drug.

9
Table of Contents for United States Generic Drugs
Market
Key Topics Covered 1. Executive Summary   2.
United States Pharmaceutical Market 2.1
Branded Pharmaceutical Market 2.2 Generics
Pharmaceutical Market   3. United States
Generic Drugs Saving   4. Market Share
United States Pharmaceutical 4.1 Branded vs.
Generics Drugs 4.2 Branded Generic vs.
Unbranded Generic Drug 4.3 Volume Penetration
Generic vs. Branded Drugs 4.4 Therapeutic
Application 5. United States Generic Drugs
Market (2010 2024) 5.1 Branded Generic Drugs
Market 5.2 Unbranded Generic Drugs Market

10
Table of Contents for United States Generic Drugs
Market
  6. Therapeutic Application United States
Generic Drugs Market (2010 2024) 6.1 Central
Nervous System (CNS) 6.2 Cardiovascular 6.3
Dermatology 6.4 Genitourinary / Hormonal
Drugs 6.5 Respiratory 6.6
Anti-infective 6.7 Oncology 6.8
Others   7. Teva Pharmaceutical Industries Ltd
- Company Analysis 7.1 Product Launch 7.2
Financial Insight   8. Mylan N.V. - Company
Analysis 8.1 Product Launch 8.2 Financial
Insight   9. Sandoz Inc. - Company
Analysis 9.1 Product Launch 9.2 Financial
Insight 10. Endo Pharmaceuticals - Company
Analysis 10.1 Product Launch 10.2
Financial Insight

11
Table of Contents for United States Generic Drugs
Market
  11. Lupin Limited - Company Analysis 11.1
Product Launch 11.2 Financial Insight   12.
Dr Reddy's - Company Analysis 12.1 Business
Portfolio 12.2 Financial Insight   13. Sun
Pharmaceutical Industries Ltd. - Company
Analysis 13.1 Product Launch 13.2
Financial Insight   14. Others 14.1
Financial Insight   15. Growth Driver 15.1
Rising Geriatric Population of United States 15.2
Generic Drugs Cost less than Brand Name
Drugs 15.3 Rising Incidence of
non-communicable Diseases   16.
Challenges 16.1 Lack of Regulation
Information 16.2 Long Halt for Expiration of
Patent Drug

12
Get Free Customization in this Report
Drugs Pharmaceuticals Market Reports
https//www.renub.com/drugs-and-pharmaceuticals-
13-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com